Insulin sensitivity and its measurement: Structural commonalities among the methods

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 12, 2000, Pages 4426-4433

  Radziuk, Jerry ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; DIET RESTRICTION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ANIMALS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER;

EID: 0034485313     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.12.4426     Document Type: Article

References (48)

1. Quantitative Insulin-sensitivity Check Index (QUICKI): A simple, accurate method for assessing insulin sensitivity in humans
2. Carbohydrate homeostasis
3. Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic clamp
4. Hepatic insulin removal following oral glucose loading in nonobese subjects with glucose intolerance and mild type 2 diabetes
5. Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose load state
6. Glucose clamp technique: A method for quantifying insulin secretion and resistance
7. Quantitative estimation of insulin sensitivity
8. A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test
9. Intravenous tolerance as a tool in definition and diagnosis of diabetes mellitus
10. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes
11. Continuous infusion of glucose with model assessment: Measurement of insulin resistance and β-cell function in man
12. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
13. Simultaneous pharmacokinetic and pharmacodynamic modeling
14. A model of insulin kinetics in man
15. Measurement and validation of non-steady turnover rates with application to the insulin and glucose systems
16. Insulin transport across capillaries is rate-limiting for insulin action in dogs
17. Dose-response characteristics for effects of insulin on production and utilization of glucose in man
18. The triumvirate: β cell, muscle, liver. A collusion responsible for NIDDM
19. Modified protocols improve insulin sensitivity estimation using the minimal model
20. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-independent diabetes
21. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance: For the insulin resistance atherosclerosis study
22. Overestimation of minimal model glucose effectiveness in presence of insulin response is due to under-modeling
23. The hot IVGTT two-compartment minimal model: Indexes of glucose effectiveness and insulin sensitivity
24. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model: Suitability for use in population studies
25. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas
26. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity
27. Insulin deficiency and insulin resistance interaction in diabetes: Estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations
28. Correct homeostasis model assessment (HOMA) evaluation uses the computer program
29. Endocrine function of canine segmental pancreatic grafts in relation to venous drainage sites and duct management
30. Does pancreatic portal venous drainage matter?
31. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis
32. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: The role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycemia. A critical comment
33. Hyperglycemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus
34. Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes
35. Understanding "insulin resistance": Both glucose resistance and insulin resistance are required to model human diabetes
36. A prospective analysis of the HOMA model
37. Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests
38. Assessment of insulin sensitivity in vivo
39. Treatment with somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose
40. Reduced glucose effectiveness associated with reduced insulin release: An artifact of the minimal model method
41. Non-insulin-mediated glucose disappearance in subjects with IDDM
42. Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans
43. The metabolic clearance of glucose: Measurement and meaning
44. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of labeled and unlabeled exogenous glucose infusates
45. Effects of insulin on glucose turnover rates in vivo: Isotope dilution versus constant specific activity technique
46. Effect of time on measurement of hepatic glucose production
47. 3H-glucose infusion
48. Hepatic glucose production during the labeled IVGTT: Estimation by deconvolution with a new minimal model